CM
CM Management Portfolio holdings
AUM
$110M
1-Year Return
9.76%
This Quarter Return
-3.12%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
-$13.3M
(-11%)
Cap. Flow
-$6.82M
Cap. Flow
% of AUM
-6.09%
Top 10 Holdings %
Top 10 Hldgs %
38.7%
Holding
66
New
2
Increased
18
Reduced
11
Closed
9
Top Buys
| 1 |
Hasbro
HAS
|
$1.12M |
| 2 |
Copa Holdings
CPA
|
$1.1M |
| 3 |
Freeport-McMoran
FCX
|
$762K |
| 4 |
Organon & Co
OGN
|
$746K |
| 5 |
Pan American Silver
PAAS
|
$607K |
Top Sells
| 1 |
Kyndryl
KD
|
$3.22M |
| 2 |
Pfizer
PFE
|
$1.74M |
| 3 |
Herc Holdings
HRI
|
$1.28M |
| 4 |
Warner Bros
WBD
|
$1.11M |
| 5 |
Perrigo
PRGO
|
$1.05M |
Sector Composition
| 1 | Healthcare | 39.52% |
| 2 | Materials | 10.9% |
| 3 | Industrials | 10.07% |
| 4 | Technology | 9.2% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
First Financial Corporation Common Stock
THFF
$710M
| $1.96M | 1.75% |
42,500
| – | – |
|
|
B
27
Barrick Mining Corporation
B
$46.5B
| $1.94M | 1.73% |
125,000
| – | – |
|
|
28
Freeport-McMoran
FCX
$66.1B
| $1.9M | 1.7% |
50,000
+20,000
| +67% | +$762K |
|
29
Cohu
COHU
$934M
| $1.87M | 1.67% |
70,000
+10,000
| +17% | +$267K |
|
30
Jazz Pharmaceuticals
JAZZ
$7.77B
| $1.85M | 1.65% |
15,000
-5,000
| -25% | -$616K |
|
31
Evolus
EOLS
$486M
| $1.66M | 1.48% |
150,000
| – | – |
|
|
32
Pan American Silver
PAAS
$12.1B
| $1.62M | 1.44% |
80,000
+30,000
| +60% | +$607K |
|
33
Xoma
XOMA
$428M
| $1.45M | 1.29% |
55,000
| – | – |
|
34
Acadia Pharmaceuticals
ACAD
$4.3B
| $1.28M | 1.15% |
70,000
| – | – |
|
|
WBA
35
DELISTED
Walgreens Boots Alliance
WBA
| $1.17M | 1.04% |
125,000
-75,000
| -38% | -$700K |
|
|
SVC
36
Service Properties Trust
SVC
$462M
| $1.14M | 1.02% |
450,000
+150,000
| +50% | +$381K |
|
37
Eledon Pharmaceuticals
ELDN
$156M
| $1.13M | 1.01% |
275,000
| – | – |
|
38
CVS Health
CVS
$93.5B
| $1.12M | 1% |
25,000
-10,000
| -29% | -$449K |
|
|
39
Hasbro
HAS
$11.3B
| $1.12M | 1% |
+20,000
| New | +$1.12M |
|
40
Heron Therapeutics
HRTX
$202M
| $1.07M | 0.96% |
700,000
+200,000
| +40% | +$306K |
|
41
AMCON Distributing
DIT
$75.5M
| $1.07M | 0.95% |
8,333
| – | – |
|
42
Atea Pharmaceuticals
AVIR
$264M
| $1.01M | 0.9% |
300,000
+30,000
| +11% | +$101K |
|
43
Coya Therapeutics
COYA
$107M
| $917K | 0.82% |
160,000
+15,941
| +11% | +$91.3K |
|
|
44
Warner Bros
WBD
$29.1B
| $740K | 0.66% |
70,000
-105,000
| -60% | -$1.11M |
|
45
Nektar Therapeutics
NKTR
$684M
| $698K | 0.62% |
50,000
| – | – |
|
46
Curis
CRIS
$21.4M
| $673K | 0.6% |
220,000
+100,000
| +83% | +$306K |
|
47
Lantern Pharma
LTRN
$45.4M
| $638K | 0.57% |
200,000
+15,000
| +8% | +$47.9K |
|
48
Cytosorbents Corp
CTSO
$61.2M
| $637K | 0.57% |
700,000
-100,000
| -13% | -$91K |
|
|
OSTX
49
OS Therapies Incorporated
OSTX
$66.1M
| $471K | 0.42% |
110,044
+60,044
| +120% | +$257K |
|
50
Femasys
FEMY
$12M
| $468K | 0.42% |
425,000
| – | – |
|